Astellas and Minovia link up on mitochondrial cell therapy programs – The Pharma Letter

Minovia Therapeutics and Japans Astellas Pharma on Friday announced a worldwide strategic collaboration

To continue reading The Pharma Letter please login,subscribeorclaim a 7 dayfree trial subscriptionand access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space.

Or, if you're only interested in reading the content about a specific topic (M&A, coronavirus/COVID-19, pricing, reimbursement and access, outsourcing, CRO and CMO, and regulation), then you can take our 10 per month channel subscription offer, which gives you access to all our news articles and in-depth content on this subject.

Go here to read the rest:

Astellas and Minovia link up on mitochondrial cell therapy programs - The Pharma Letter